DSpace Repository

Global Andrology Forum (GAF) Clinical Guidelines on the Management of Non-obstructive Azoospermia: Bridging the Gap between Controversy and Consensus

Show simple item record

dc.contributor.author Hamoda, T.
dc.contributor.author Shah, R.
dc.contributor.author Mostafa, T.
dc.contributor.author Germar-Michael, P.
dc.contributor.author Atmoko, W.
dc.contributor.author Balagobi, B.
dc.date.accessioned 2025-07-24T06:15:13Z
dc.date.available 2025-07-24T06:15:13Z
dc.date.issued 2025
dc.identifier.uri http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11432
dc.description.abstract Purpose: Non-obstructive azoospermia (NOA), defined as the absence of sperm in the ejaculate due to testicular failure, is observed in 5% to 15% of infertile men and accounts for two-thirds of azoospermia cases. The management of NOA is marked by significant controversy and global variation in diagnostic and therapeutic approaches, highlighting the crucial need for well-designed and standardized clinical practice guidelines. We present comprehensive graded clinical practice recommendations and statements for diagnosing and treating NOA, aiming to establish standardized strategies that can glob- ally help guide practitioners in their practice. Materials and Methods: A comprehensive literature review was conducted to gather evidence on the epidemiological, di- agnostic, and therapeutic aspects of NOA. The Global Andrology Forum (GAF) recommendations were developed through the collaboration of a global panel of experts using the Delphi method and surveys to achieve consensus. Statements were graded according to the Oxford Centre for Evidence-Based Medicine “GRADE” classification as either “Strong” or “Weak.” Statements receiving at least 80% expert consensus were graded as “Strong,” while others were categorized as “Weak.” Results: The GAF has formulated a total of 49 recommendations and statements on the diagnosis and treatment of NOA, in- cluding 21 for diagnosis and 28 for treatment. The recommendations and statements were evaluated and graded by a panel of 48 GAF experts from 25 countries worldwide. The majority of experts (60.5%) had more than 10 years of clinical experi- ence in managing NOA. Conclusions: The GAF guidelines address discrepancies in NOA management across diverse clinical settings and provide comprehensive graded recommendations to guide clinicians in its diagnosis and treatment. Developed and graded by a large worldwide panel of experts, the current guidelines present simplified, high-standard strategies that can be seamlessly inte- grated into the daily global practice, offering practitioners a clear framework for managing NOA. en_US
dc.language.iso en en_US
dc.publisher Korean Society for Sexual Medicine and Andrology en_US
dc.subject Azoospermia en_US
dc.subject Guideline en_US
dc.subject Infertility en_US
dc.subject Pregnancy en_US
dc.subject Semen en_US
dc.subject Sperm retrieval en_US
dc.title Global Andrology Forum (GAF) Clinical Guidelines on the Management of Non-obstructive Azoospermia: Bridging the Gap between Controversy and Consensus en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record